Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19


Authors: Martin Dugas 1, Tanja Grote-Westrick 2, Uta Merle 3, Michaela Fontenay 4, Andreas E Kremer 5, Frank Hanses 6, Richard Vollenberg 7, Eva Lorentzen 8, Shilpa Tiwari-Heckler 9, Jérôme Duchemin 10, Syrine Ellouze 11, Marcel Vetter 12, Julia Fürst 13, Philipp Schuster 14, Tobias Brix 15, Claudia M Denkinger 16, Carsten Müller-Tidow 17, Hartmut Schmidt 18, Phil-Robin Tepasse 19, Joachim Kühn 20 Abstract Background: The vast majority of COVID-19…[...]

Resolving “Long-Haul COVID” and Vaccine Toxicity: Neutralizing the Spike Protein


Authors: Dr. Thomas E. Levy, MD, JD July 1, 2021 Although the mainstream media outlets might have you believe otherwise, the vaccines that continue to be administered for the COVID pandemic…[...]

Ivermectin for COVID-19: real-time meta analysis of 63 studies


Authors: Covid Analysis, Aug 12, 2021, Version 109 — twitter personality response, added Together Trial (V1 Nov 26, 2020) •Meta analysis using the most serious outcome reported shows 73% and 86% improvement for early treatment and…[...]

Underlying Medical Conditions and Severe Illness Among 540,667 Adults Hospitalized With COVID-19, March 2020–March 2021


Authors: Lyudmyla Kompaniyets, PhD1; Audrey F. Pennington, PhD1; Alyson B. Goodman, MD1,2; Hannah G. Rosenblum, MD1,3; Brook Belay, MD1; Jean Y. Ko, PhD1,2; Jennifer R. Chevinsky, MD1,3; Lyna Z. Schieber,…[...]